1 0 9 4 VOLUME 24 NUMBER 12 DECEMBER 2017 nature structural & molecular biology a r t i c l e s the generally held view that lipid-free apoA-I is a four-helix bundle in a pseudo-stable state poised to interact with lipids. However, looking more deeply, the models differ widely in shape, secondary structure placement and the location of the N and C termini. Thus, the field still lacks the structural detail to understand how apoA-I binds lipids, interacts with ABCA1 to form mature HDL, exchanges between HDL and mediates particle interactions with plasma-borne remodeling factors.
In the absence of a high-resolution structure of lipid-free apoA-I but with the benefit of nearly five decades of spectroscopic and crosslinking data, we assembled a group of apoA-I structural investigators, the ApoA-I Working Group, to derive a consensus model that consolidates the apoA-I structural literature. In addition, we report new cross-linking data to round out a universal list of 95 distance constraints from three laboratories, using multiple cross-linking reagents. We also included new molecular-shape data from SAXS and incorporated secondary structural information from HDX 12 . Using the crystal structure of dimeric apoA-I (ref. 4 ) as a template, we applied iterative computer modeling techniques to derive the new model.
RESULTS

Cross-linking and SAXS analyses
We used the homobifunctional cross-linkers CBDPS (cyanur-biotin-dimercapto-propionyl-sulfo-succinimide) and BS3 (bis(sulfosuccinimidyl) suberate), both NHS esters that cross-link lysine and, to a lesser extent, serine residues 18, 19 . Wild-type ( 14 N) and isotopically labeled ( 15 N) apoA-I were mixed 1:1 under denaturing conditions. This allowed unambiguous peptide identification and confirmation that cross-links were not due to oligomerization 5 . After cross-linking, monomeric apoA-I was isolated by size-exclusion chromatography (SEC). We routinely obtained >95% purity of cross-linked monomeric apoA-I, as shown using SDS-PAGE ( Supplementary Fig. 1 ). Supplementary Tables 1 and 2 list the 65 cross-linked peptide pairs that were identified (criteria in Online Methods). All cross-links exhibited a dual-peak pattern, indicating intramolecular span 5, 20 . 45 linkages were identified in both BS3-and CBDPS-treated samples, with 15 unique to BS3 and five unique to CBDPS.
We used SAXS to assess the shape of monomeric apoA-I in solution. ApoA-I's propensity for concentration-dependent self-association posed a challenge, because reliable SAXS data collection requires concentrations up to 4 mg/ml. We circumvented this issue by performing SAXS on apoA-I that had been locked into the monomeric state by cross-linking with BS3 or CBDPS (Online Methods). Careful evaluation using SEC showed that this method prevented further oligomerization. The SAXS parameters are shown in Supplementary Table 3 .
For both cross-linking reagents, scattering intensity increased proportionally with sample concentration, and the Guinier range was linear at low scattering angles (not shown), indicating no concentration-dependent effects and good data quality. No significant differences were observed in R g (Guinier and real space) and D max , and comparable molecular volumes were found across all concentrations. Additionally, scattering profiles and pairwise distribution plots for both samples were highly related ( Fig. 2a,b ). There may be small differences in the flexibility of differentially cross-linked apoA-I species. ApoA-I cross-linked with CBDPS showed a dip in the q 3 × I(q) plot ( Fig. 2c) and a plateau in the q 4 × I(q) plot ( Fig. 2d) , indicative of a folded, rigid structure. The BS3-treated sample exhibited a plateau in the q 3 × I(q) plot and a lack of plateau in the q 4 × I(q) plot, thus indicating a possible flexible domain. The deviation in dynamics is likely due to differences in cross-linking efficiency, as much less CBDPS is required for linking oligomers than BS3. The R g of both samples were similar (25.35 ± 0.15 Å and 25.34 ± 0.17 Å for CBDPS and BS3, respectively) and, taken with the pairwise distribution plots, suggested that apoA-I had characteristics of a globular protein. Twenty-three independent envelope reconstructions were performed and averaged using DAMMIF 21 to generate a composite. Both DAMMIF reconstructions had normalized spatial discrepancies (NSD) between 0.5 and 0.7 ( Supplementary Table 3 ), indicating good convergence of the independent reconstructions. The envelopes ( Fig. 2e,f ) serve as a low-resolution representation of the overall shape of the molecule, which can be used as a rough tool for visualizing the fit of a model. ApoA-I cross-linked with CBDPS had a calculated volume of ~69,400 Å 3 compared to ~79,500 Å 3 for that cross-linked with BS3, consistent with the more flexible nature of the BS3 sample. Taken together, the data suggest minimal structural differences between the samples.
Generation and evaluation of the model
The starting construct of the model was derived from the crystal structure of apoA-I 1-184 , as shown in Supplementary Figure 2 . As Mei and Atkinson 4 proposed, an inflection point was first placed in helix H5, near the center of the long helix shared by two protomers (A and B) in the dimer. However, guided by cross-linking constraints and SAXS, the inflection point was shifted more C terminal to residue 139 in H5. The C-terminal portion of monomer A was then folded back, resulting in the juxtaposition of H6 (A) and H5 (A) (Supplementary Fig. 2b ). Using PyMOL (http://www.pymol.org) and Modeller (v9.14), the a r t i c l e s missing residues 185-243 were threaded in and positioned, guided by the relevant cross-linking constraints 10, 11, 16 ( Supplementary Table 4 ). This construct was used as a base model for further refinement. Next, secondary structural data derived exclusively from HDX 12 was implemented onto the base model. This required conversion of helical segments observed in the crystal structure to random coil (and vice versa in some cases). Then, the entire model was simultaneously refined for fit to the SAXS scattering curves and the cross-linking data, while holding the secondary structure assignments as constant as possible. Lastly, the model was subjected to energy minimization using YASARA 22 , and side chain rotamers were manually refined in COOT 23 (details of each step in Online Methods). The final model ( Fig. 3) depicts monomeric, lipid-free apoA-I as a helical bundle composed of three main helices: H1 (residues 8-35), H5 (81-115) and H6 (148-179). Three shorter helical regions are interspersed between these helices: H2 (37-45), H3 (54-64) and H4 (68-78). The remainder is random coil with two main stretches spanning residues 116-147 and the entire C terminus, residues 180-243. The C terminus forms a globular domain that sits on the bundle at the N-terminal end of H5 and the C-terminal end of H6. The N and C termini are located near each other at the base of the bundle and opposite the bulk of the C-terminal globular domain. Proline residues at positions 7 and 66 reside in regions of transition between helix and random coil, with residue 66 clearly mediating a turn structure.
Although most of the other prolines are located in random-coil regions, prolines 99 and 165 occur in the middle of H5 and H6, respectively, without apparent disruption.
Compatibility of the model with old and new experimental data
A contact plot of the final structure is shown in Figure 4a , with experimental cross-links superimposed in blue and violations in red. Overall, 89 of 95 cross-links (both previously published and newly reported here) were consistent with the model. It is worth noting that this is 3-5 times the number of constraints used in previous modeling attempts, significantly reducing the conformational possibilities that can fit the data. The six violations were, on average, within ~2 Å of the allowable span. Figure 4b shows the model agreement with the HDX data of Chetty et al. 12 . The new model has 235 of 243 residues (97%) assigned in keeping with the HDX data. The small differences resulted from tradeoffs made for optimal cross-link and SAXS data fitting. These differences occurred near residue 36, which is predicted to form the minor H2 helix (also observed in the crystal structure 4 ). The remaining differences involved 1-2 amino acids bookending α-helical regions. Figure 4c shows the model superimposed onto both DAMMIF ab initio molecular envelopes generated from recombinant apoA-I cross-linked with CBDPS and BS3. The primary measure of agreement to SAXS was the model fit to the scattering curves. Figure 4d ,e shows that the model was in good agreement with both SAXS scattering curves (χ = 1.13 and χ = 0.81 for CBDPS and BS3, respectively). As a point of reference, our previous work compared a crystal structure of a truncation mutant of apoA-IV with similarly obtained SAXS data with a χ = 0.97 (ref. 20) .
We also reviewed the literature for additional structural data for lipid-free apoA-I collected under conditions in which it was monomeric. Supplementary Table 5 summarizes numerous studies that used far-UV CD to estimate α-helix and random-coil contents. α-helical content ranged from 40% to 68% across 27 studies, for an average of 52 ± 6% or 126 ± 14 residues. The new model, driven primarily by the HDX restraints, matched exactly, with 126 α-helical residues. Another technique for identifying areas of low structural organization is limited proteolysis. Supplementary Table 6 summarizes two studies that applied this technique to primarily monomeric apoA-I. Proteolytically susceptible sites (highlighted on the new model in Fig. 5a ) tended to occur in random-coil areas near the molecule surface. The solvent accessibility of these sites in the new model, as assessed using VADAR 24 , was highly consistent with the proteolysis data, with only Supplementary Figure 3 summarizes how the new model compares to the eight published models of monomeric apoA-I with respect to the experimental data outlined above. In most cases, the new model showed considerably improved compatibility with the data.
DISCUSSION
Lipid-free apoA-I is of direct physiological relevance because it and its related forms (such as preβ1-HDL) are essential to de novo HDL biogenesis via ABCA1-mediated efflux of phospholipid and cholesterol, a critical anti-atherogenic pathway in human plasma 25 . This involves direct interaction of apoA-I with both ABCA1 and specialized domains in the plasma membrane 26, 27 . The concentration of total apoA-I in human plasma is about 130 mg/dL (~50 µM). At 5-10% of total apoA-I (ref. 28 ), lipid-free apoA-I in plasma is around 2 µM and should be mostly monomeric. In peripheral lymph (interstitial fluid), the concentration is about ten-fold less concentrated (~0.2 µM or about 5 µg/ml), corresponding to the K m for lipid efflux via ABCA1 (ref. 29 ). Thus, a detailed understanding of apoA-I in its most nascent biophysical state (lipid-free and monomeric) will aid in our understanding of HDL biogenesis and its eventual interaction with critical HDL mediators, such as plasma lecithin-cholesterol acyl transferase. A solution to this problem has been pursued intensively for decades, but a high-resolution structural model of apoA-I's native form has remained elusive. The model described here represents a comprehensive multitechnique attempt to address this issue, given apoA-I's recalcitrance to traditional high-resolution structural techniques. We first describe the features of the model, touch on its implications for understanding HDL biology and then discuss its limitations. a r t i c l e s structure, particularly highly unstable helices that cannot be detected at the timescale of the HDX experiments. Indeed, truncation of the C terminus from residue 243 to residues 231 and 221 reduced the CD-detectable-helix content by seven and 14 amino acid residues, respectively 30, 31 .
On the basis of such observations, Mei and Atkinson 31 suggested that the segment spanning residues 231-241 contains an α-helical structure. Such a C-terminal helix is further supported by preliminary molecular dynamics simulations of the new model (Segrest et al., unpublished observation). Overall, the C-terminal domain sits on N-terminal αhelical domains H1 and H2 (Fig. 5, dark blue) , with the termini residing close to each other. This theme was also observed in the solution structure for apoA-IV (ref. 20) and may explain structural and energetic studies indicating that the N-and C-terminal domains of apoA-I act cooperatively to modulate its stability 32 and lipidation kinetics 5,33-36 .
The space-filling illustration in Figure 5b shows that the model is well packed, particularly in the N-terminal domain, with hydrophobic faces of the helices oriented toward the bundle core. However, there are clear instances of solvent-exposed hydrophobic residues, possibly contributing to the protein's low thermodynamic stability 37 . Another intriguing feature is two potential networks of aromatic residues (Fig. 5c) .
Aromatic residues play important roles in protein stability, protein-protein interactions and tertiary folding 38 . Indeed, the natural mutations G26R in apoA-I IOWA 39 and R173C in apoA-I MILANO 40 both result in substantial decreases in free energy of denaturation of lipid-free apoA-I (ref. 41) , and both are central to an aromatic cluster that potentially stabilizes helices 1, 5, and 6 ( Fig. 5d) . Lastly, residues reported by Gorshova and colleagues 33, 42 to be critical for apoA-I stability (Fig. 5e , space filled in red) exhibit remarkable colocalization with the aromatic clusters highlighted in Figure 5c . The model predicts that additional mutations in these areas should affect stability and likely the propensity to oligomerize and interact with lipids.
We considered the new model in light of apoA-I's propensity to self-associate. Figure 6 compares the consensus model to the crystal structure of dimeric apoA-I 1-184 and its monomer, as postulated by Mei et al. 4 . Comparing Figure 6b and c, the full-length model shares numerous features with the postulated monomer. Both models show an N-terminal helix between residues 7 and 36, situated alongside another helix composed of residues 80-116. Though these helices are bent more acutely in the full-length model, the interhelical interactions are similar. Also, the N termini of both models are in proximity to a short helix of residues ~66-76. The full-length model shows a large random-coil region between residues 116-147 that acts as a turn, allowing H6 (residues 148-178) to double back and participate in the helical bundle. Although more ordered in the crystal model, a similarly centered turn (near residue 129) generates an intramolecular helical bundle. The main difference is that in the full-length model, the position of H6 is shifted relative to that of the bundle, perhaps by the presence of residues 185-243 that sit against the bundle (note how the red helix in Fig. 6c is shifted to the right compared to that in Fig. 6b) . Given the relative agreement with the monomeric model derived from the crystal structure, it follows that the full-length protein may dimerize similarly to the crystal structure dimer. Figure 6d ,e show how this might occur. By placing a hinge point near residue 129, the C-terminal portion of full-length apoA-I can be extended to interact with a similarly extended apoA-I partner. Aside from the increased random-coil structure in the consensus-model dimer, many of the intermolecular alignments seen in the apoA-I 1-184 dimer are highly plausible. Thus, we propose that the dimer-monomer conversion scheme proposed by Mei et al. for apoA-I 1-184 is compatible with the new consensus model and may describe how the full-length protein dimerizes. Further experimental work is required to test this hypothesis.
We also considered the implications of the new model for apoA-I lipid binding and HDL biogenesis. There is a general consensus that lipid binding is initiated when the relatively unstable C-terminal domain comes in contact with a lipid surface 31, [43] [44] [45] , either via a packing defect 46 or an ABCA1-mediated mechanism 26 . It is easy to visualize the periodic movement of the C terminus away from the helical bundle in the consensus model. If it encounters lipid, the formation and/or stabilization of C-terminal helices provides a favorable ∆G (ref. 30 ) that drives further lipid association. There is also evidence that the N terminus may play a role in initial lipid contact 35, 47 . Freed of the C-terminal domain, the bundle helices can then unpack, reorienting the hydrophobic faces of the central part of apoA-I to penetrate the lipid surface 35 . One of the main benefits of having the consensus structure is that it gives a 'road map' to the initial position of the helices and offers a structural basis for how they may unpack during this transition. For example, Saito et al. speculated that H1 and H2, based on their similar low stabilities, may be in close opposition and unfold as a unit 30 early on in the lipid-binding process. Our model shows that H2 (in our case, residues 50-80) forms a bent helix that actually wraps around H1, thus supporting this idea.
There is considerable debate over the exact subsequent steps involved in the creation of a nascent HDL particle. Key questions remain as to the role and timing of apoA-I dimerization (Does it happen before, during or after lipidation?) and the exact mechanism and role of ABCA1 (Does it play a role in apoA-I dimer formation, and how does it physically load lipid onto apoA-I?). A recent cryo-EM a r t i c l e s structure of ABCA1 offers interesting possibilities 48 , but a consensus on how this mechanism works has yet to materialize. In Figure 7 , we show a simplified scheme consistent with that proposed by Mei et al. 31 of how the consensus model could be unpacked to generate a ring-like conformation, as proposed for the double-belt structure of apoA-I in discoidal HDL particles 49 . We caution that this scheme is only one of many possibilities, and the role of apoA-I dimerization and ABCA1 was intentionally not addressed. Now that we have good ideas of the structures of both apoA-I and ABCA1, we look forward to exciting new work on this critical mechanism. Despite its consistency with much of the known structural data, we note that the model is still limited in resolution compared to those from NMR or X-ray crystallography. The general backbone configuration is likely correct, but more refined molecular interactions such as salt bridging and hydrogen bonding remain unclear. Additionally, one might question whether it is possible to represent a highly dynamic protein with a single, time-averaged model. ApoA-I has a ∆G of helix stabilization ranging from ~3-5 kcal/mol 12 . At neutral pH and room temperature, HDX studies have demonstrated complete hydrogen exchange into apoA-I α-helical segments occurring in ~10 min (Supplementary Fig. 4) ; all apoA-I helical segments unfolded and reformed at least once in this timeframe. To put this finding into context, a stable globular protein like cytochrome c has a ∆G of helix stabilization of 10 kcal/mol, with complete hydrogen exchange requiring ~10 weeks. Given this degree of dynamics, it seems likely that, at physiological temperatures, apoA-I exists in an ensemble of related structures at any point in time. Indeed, the fact that some cross-links failed to fit the model (six were close, but not strictly allowed) directly suggests differential conformations. Our model is a time-averaged structure derived from experimental data obtained on a longer time scale than that of typical secondary structure oscillations. For this reason, we think of it as a base model upon which hypothesized dynamics and conformational alterations can be further modeled and tested. However, because the majority of cross-links did fit the model and the SAXS patterns showed consistent molecular shapes, we argue that the consensus model probably reflects a majority of the molecules existing at a given time or that any conformers exhibit related shapes and structures.
Another issue relates to the notion of solvent accessibility of the cross-linking reagents. Whereas most cross-links fit the model in terms of Euclidian distance ('as the crow flies'), many are impeded by some obstruction, like a side chain from a nonparticipating residue or an adjacent helical domain. Given that the model represents a time average of an ensemble of related apoA-I structures, cross-links that appear sterically hindered or solvent inaccessible could occur on an alternate conformation within the boundaries of the experimental system. Additional studies are needed to better define these boundaries and the extent of rearrangement apoA-I can achieve in vivo and in vitro. Additionally, the constant unfolding of helical domains over the course of the experiment could allow cross-links that might not be expected in a static structure. Nevertheless, previous reports have shown excellent consistency between observed cross-links in solution with crystal structures of apoA-I 1-184 (ref. 5) and apoA-IV (ref. 20) and non-apolipoproteins [50] [51] [52] [53] validating the approach. Importantly, instances of steric cross-linker hindrance were also routinely observed in these studies. A more detailed discussion of potential limitations of the model is presented in the Supplementary Note and Supplementary Table 7 .
In summary, we propose a new time-averaged model of the structure of apoA-I in solution that is, by and large, consistent with decades worth of experimental data. Although still lacking amino acid level resolution, it provides a much-needed starting point upon which to test structural hypotheses with regard to loss-of-function mutations, interaction with cell-surface proteins and HDL formation.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
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Data exclusions
Describe any data exclusions.
No data was excluded from the generation of the model. Indeed, we found some cross-links, for example, that did not strictly fit the final model. These were still included in the reporting. In some cases, SAXs samples that showed clear signs of aggregation were repeated with new preps.
Replication
Describe whether the experimental findings were reliably reproduced.
This model was produced from multiple preparations of native and recombinant apoA-I with two separate cross-linking agents. This study is unique in that it utilized structural data from at least 4 different laboratories. Our comparisons showed the most of the reported chemical cross-links were indeed reproducible among these laboratories. This is despite differences in cross-linking agent, sample processing and mass spectrometry equipment. A strength of this study is that the data was not only produced in a single lab. Thus, by definition, it is reproducible across laboratories
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Not applicable: This structural study did not have an experimental group design.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
This work primarily utilized protein structure modeling software platforms that are freely available on the Web. These include Modeler v9.14 (https://salilab.org/ modeller/), FoxS (https://modbase.compbio.ucsf.edu/foxs/), YASARA (http:// www.yasara.org/homologymodeling.htm), COOT (http://www.ysbl.york.ac.uk/ lohkamp/coot/wincoot.html), and MolProbity (http:// molprobity.biochem.duke.edu/). For the cross-linking data analysis, we used SIM-XL, which we helped to develop (http://patternlabforproteomics.org/sim-xl/). For mass spectrometry, we used the manufacturer provided software to analyze the data (Agilent, Qualitative Analysis).
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
